홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

2,2'-[iminobis(methylene)]bis(N,N-dimethyl-1H-imidazole-1-sulfonamide) → tert-butyl 2-(4-{[bis({1-[(dimethylamino)sulfonyl]-1H-imidazol-2-yl}methyl)amino]methyl}benzyl)-3-oxo-2,8-diazaspiro[4.5]decane-8-carboxylate

HRID 2313005
노트
인쇄 미리보기

반응식

HRID 2313005 반응식
[CH:1](=[O:2])[c:3]1[cH:4][cH:5][c:6]([CH2:7][N:8]2[CH2:9][C:10]3([CH2:11][C:12]2=[O:13])[CH2:14][CH2:15][N:16]([C:19](=[O:20])[O:21][C:22]([CH3:23])([CH3:24])[CH3:25])[CH2:17][CH2:18]3)[cH:26][cH:27]1.[NH:28]([CH2:29][c:30]1[n:31]([S:35](=[O:36])(=[O:37])[N:38]([CH3:39])[CH3:40])[cH:32][cH:33][n:34]1)[CH2:41][c:42]1[n:43]([S:47](=[O:48])(=[O:49])[N:50]([CH3:51])[CH3:52])[cH:44][cH:45][n:46]1>>[CH2:1]([c:3]1[cH:4][cH:5][c:6]([CH2:7][N:8]2[CH2:9][C:10]3([CH2:11][C:12]2=[O:13])[CH2:14][CH2:15][N:16]([C:19](=[O:20])[O:21][C:22]([CH3:23])([CH3:24])[CH3:25])[CH2:17][CH2:18]3)[cH:26][cH:27]1)[N:28]([CH2:29][c:30]1[n:31]([S:35](=[O:36])(=[O:37])[N:38]([CH3:39])[CH3:40])[cH:32][cH:33][n:34]1)[CH2:41][c:42]1[n:43]([S:47](=[O:48])(=[O:49])[N:50]([CH3:51])[CH3:52])[cH:44][cH:45][n:46]1
참가 물질출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 672857942,2'-[iminobis(methylene)]bis(N,N-dimethyl-1H-imidazole-1-sulfonamide)HCID 87423993Tert-butyl 2-[(4-formylphenyl)methyl]-3-oxo-2,8-diazaspiro[4.5]decane-8-carboxylate

생성물 1

HCID 67502412tert-butyl 2-(4-{[bis({1-[(dimethylamino)sulfonyl]-1H-imidazol-2-yl}methyl)amino]methyl}benzyl)-3-oxo-2,8-diazaspiro[4.5]decane-8-carboxylate

출처 및 근거

ORD 기록
ord-b086978d29aa47d6b30d022b241b44be
출처 데이터셋
Training data from https://doi.org/10.1039/C8SC04228D (10/10)
DOI
10.1039/C8SC04228D

반응 노트

불러오는 중…

이 페이지에서참가 물질출처 및 근거반응 노트